Jonas V. Alsenas

Jonas V. Alsenas

Finance
Consumer Services
Health Technology

Profile

Prior to joining Leerink Swann in 2008, Dr. Alšenas was a consultant to the biotechnology industry.
From 2003 to 2004, he was the CEO and a director of Prana Biotechnology, Ltd.
in Melbourne, Australia.
In addition to his industry background, Dr. Alšenas has extensive buy- and sell-side Wall Street experience.
He was a Managing Director (Research Analyst/Portfolio Manager) at ING Investment Management from 2000 to 2003.
From 1996 to 2000, he was a Managing Director and Senior Biotechnology Research Analyst at ING Barings/Furman Selz where his professional recognition included being named an All-Star Analyst by the Wall Street Journal for both stock-picking and earnings accuracy.
From 1991 to 1996, Dr. Alšenas was a Vice President at Scheer & Company where he consulted for institutional investors as well as biopharmaceutical industry clients.
Dr. Alšenas earned his D.V.M.
from the Ohio State University College of Veterinary Medicine and his B.A.
from Northwestern University.

Former positions of Jonas V. Alsenas

CompaniesPositionEnd
ALTERITY THERAPEUTICS LIMITED President 15/06/2005
Analyst-Equity 30/12/2002
Furman Selz LLC Analyst-Equity 30/12/2000
Corporate Officer/Principal 30/12/1995
Analyst-Equity -
See the detail of Jonas V. Alsenas's experience

Training of Jonas V. Alsenas

Northwestern University Undergraduate Degree
The Ohio State University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jonas V. Alsenas's experience

Connections

43

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ALTERITY THERAPEUTICS LIMITED

Health Technology

Private companies4

Finance

Finance

Furman Selz LLC

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Jonas V. Alsenas